Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) антитело. Pelgifatamab can be covalently linked to a связывание moiety of 225Ac and used for metastatic castration-resistant prostate cancer (mCRPC) research.
Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody. Pelgifatamab can be covalently linked to a binding moiety of 225Ac and used for metastatic castration-resistant prostate cancer (mCRPC) research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.